Press Releases

Ribo-Seq Service Now Available on CD Genomics’s RNA Solutions Platforms

RNA Solutions is the platform that offers services on the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. To further enrich its service types, the company recently announced to add Ribo-Seq to its offerings.

Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.

DDA Platform Offers Wide Range of Genetoxicity Testing Services to Accelerate Different Phases of Drug Discovery

Acroscell Offers Cardiac Ion Channel Screen Panels to Detect and Analyze Effects of Candidate Drugs

Creative Bioarray Develops State-of-art Cell Based Assay to Support Biomedical Research and Drug-discovery Process

Microbialtec Platform Develops Chemotaxonomy-based Drug Discovery to Accelerate The Development of Drug Discovery

IntegrateRNA Develops One-stop Solutions for Oligonucleotide Conjugation Services to Facilitate Diagnostic and Targeted Drug Delivery

Microbiosci Offers Reliable Strain Selection and Fermentation Services to Suit The Needs of Microbial Research

Certified Reference Materials for Chromatography Are Now Available at Alfa Chemistry

BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification

CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions

CD Formulation Optimizes Elemental Impurities Analysis Service

Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye

Biotium has announced the release of EMBER500™ RNA Prestain Loading Dye.

Emmes Acquires Institut Dr. Schauerte

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Sensyne Health and Cambridge University Hospitals NHS Foundation Trust Sign Strategic Research Agreement

Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients

DFE Pharma researcher recognized as one of the 2021 Outstanding Early Career Scientists

CluePoints Wins Scrip Award for Clinical Advance of the Year 2021

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards.